PMID: 26831267Feb 3, 2016Paper

Novel Therapeutic Strategies for Dementia

CNS & Neurological Disorders Drug Targets
Ramon CacabelosGjumrakch Aliev

Abstract

Dementia represents a major problem of health and disability, with a relevant economic impact on our society. Despite important advances in pathogenesis, diagnosis and treatment, its primary causes still remain elusive, accurate biomarkers are not well characterized, and the available pharmacological treatments are not cost-effective. Alzheimer disease (AD), the most prevalent form of dementia, is a polygenic/multifactorial/complex disorder in which hundreds of defective genes distributed across the human genome may contribute to its pathogenesis. Diverse environmental factors, cerebrovascular dysfunction, and epigenetic phenomena, together with structural and functional genomic dysfunctions lead to amyloid deposition, neurofibrillary tangle formation and premature neuronal death, the major neuropathological hallmarks of AD. For the past 20 years, over 1,000 different compounds have been studied as potential candidate drugs for the treatment of AD. About 50% of these substances are novel molecules obtained from natural sources. The candidate compounds can be classified according to their pharmacological properties and/or the AD-related pathogenic cascade to which they are addressed to halt disease progression. In addition to th...Continue Reading

Citations

Sep 15, 2017·Evidence-based Complementary and Alternative Medicine : ECAM·Taiwo Olayemi ElufioyeSolomon Habtemariam
Dec 14, 2019·Journal of Clinical Psychopharmacology·Laura BorghansArjan Blokland
Apr 22, 2017·CNS Neuroscience & Therapeutics·Lan-Xue ZhaoYu Qiu
Jul 24, 2018·International Journal of Alzheimer's Disease·Aristo Vojdani, Elroy Vojdani
Jun 12, 2018·Neurodegenerative Disease Management·Andrea Stoccoro, Fabio Coppedè
Mar 16, 2019·International Journal of Molecular Sciences·Ramón CacabelosDmitry Goldgaber
Jan 6, 2018·Journal of Personalized Medicine·Ramón CacabelosÓscar Teijido
Apr 3, 2018·Expert Opinion on Drug Discovery·Ramón Cacabelos
Jan 29, 2020·Current Neuropharmacology·Vivek Kumar SharmaThakur Gurjeet Singh
Aug 20, 2020·Seminars in Cancer Biology·Margarita E NeganovaGjumrakch Aliev
Jun 14, 2016·Pharmacogenomics·Ramón CacabelosJuan Carlos Carril

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.